Full Text View
Tabular View
No Study Results Posted
Related Studies
Risk of Cancer in Users of Regranex (Becaplermin) and Matched Comparators
This study is ongoing, but not recruiting participants.
Study NCT00518102   Information provided by Ethicon, Inc.
First Received: August 16, 2007   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cancer
Foot Ulcer, Diabetic
Diabetic Foot
Foot Ulcer
Neoplasms
Additional conditions recognized in this trial
Ulcer
More general conditions related to this trial
Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Diabetic Angiopathies
Diabetic Neuropathies
Endocrine System Diseases
Foot Diseases
Leg Ulcer
Pathologic Processes
Skin Diseases
Skin Ulcer
Vascular Diseases
Additional drug interventions recognized in this trial
Platelet-derived growth factor BB
More general drug interventions related to this trial
Angiogenesis Inducing Agents
Angiogenesis Modulating Agents
Growth Substances
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Ethicon, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services